Aurobindo Pharma Ltd. Financials

NSE BSE

15:52 Jul 30

Aurobindo Pharma Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

1158.00

-0.10 (-0.01%)

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

NSE BSE

Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals

1158.00

-0.10 (-0.01%)
15:52 Jul 30

Quality

66/100
High Financial Strength

Valuation

48/100
Mid Valuation

Technical

42/100
Technically Neutral

Strength

Weakness

Opportunity

Threats

ROE %

ROA %

EPS

BVPS

Net Profit Margin

Income Statement Balance sheet Cash flow Ratio Shareholding

Quarterly Annual

Consolidated Standalone

	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Net Sales	24774.62	23455.49	24855.38	29001.87	31723.73
Operating Expenses +	19441.22	19068.72	21136.74	23158.87	25140.94
Raw Material	10632.68	9323.6	11702.94	13549.07	13623.87
Increase Decrease in Cost	-730.21	816.68	-409.68	-946.17	-597.63
Other Manufacturing Expense	0	0	0	0	0
Employee Cost	3535.02	3450.92	3522.25	3922.94	4475.62
Miscellaneous Expenses	10634.57	9381.06	10422.09	12178.89	13413.3
Operating Profit	5333.4	4386.77	3718.64	5843	6582.79
Other Income	380.85	320.35	290.59	557.38	621.85
Depreciation	1055.39	1126.52	1244.58	1521.66	1649.42
Interest	74.49	48.64	140.48	289.71	457.24
Profit before tax and exceptio..	4584.37	3531.96	2624.17	4589.01	5097.98
Exceptional Items	2814.58	-127.97	0	-191.86	0
PBT	7398.95	3403.99	2624.17	4397.15	5097.98
Provision for Taxation	2009.77	725.63	684.85	1211.02	1582.72
Net Profit	5389.18	2678.36	1939.32	3186.13	3515.26
NET Profit after MI	5334.84	2648.15	1927.5	3172.97	3485.88
EPS	91.05	45.19	32.9	54.16	59.81
Operating Profit Margin (%)	21.53	18.7	14.96	20.15	20.75
Net Profit Margin (%)	21.53	11.29	7.75	10.94	10.99

All Data in Percentage (%)

	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24
Promoter	51.80	51.80	51.80	51.80	51.80
FII	14.40	15.30	16.30	16.60	16.70
MF	19.00	18.20	17.80	18.50	19.20
Others	7.90	8.10	7.40	6.60	5.60

Promoter Non-Promoter

Shareholder	Shares	Holding %

Download Our App On: